Project Grant R01CA295109
Award Date
7/17/24
Completion Date
6/30/29
Dollars Obligated
$603K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
This federal Project Grant award, funded by the National Cancer Institute under the 21st Century Cures Act - Beau Biden Cancer Moonshot (CFDA 93.353) program, supports a randomized controlled trial to assess the efficacy of a phone-delivered positive psychological intervention (PATH) for improving anxiety, depression, and quality of life in hematopoietic stem cell transplantation (HSCT) survivors. The total award amount is $746,926, with a project period from July 2024 to June 2029. The...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will fund a 5-year, $599,339 randomized trial to evaluate the efficacy of a multidisciplinary group-based telehealth intervention called HORIZONS. The intervention aims to improve quality of life, psychological distress, symptom burden, coping, and self-efficacy in hematopoietic stem cell transplant (HCT) survivors living with chronic graft-versus-host disease...
The National Cancer Institute (NCI) awarded Duke University a $1,123,468 Project Grant under the Cancer Treatment Research (CFDA 93.395) program. The grant, awarded on July 1, 2024, supports a randomized controlled trial of a hybrid-delivered cognitive behavioral symptom management and activity coaching intervention for hematopoietic stem cell transplant (HCT) patients. The intervention, titled "STEP UP," aims to enable HCT patients to effectively cope with symptoms such as fatigue,...
The National Cancer Institute (NCI) awarded a $794,530 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the Sloan-Kettering Institute for Cancer Research to conduct a phase IIb randomized controlled trial evaluating the efficacy of time-restricted eating to reduce weight and improve markers of cardiometabolic risk in 300 radiation-exposed survivors of childhood cancer with overweight/obesity. The study will leverage novel mHealth technology to deliver a remote,...
This federal Project Grant award of $293,053, provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program, aims to develop and pilot test a palliative care intervention tailored for patients with hematologic malignancies undergoing adoptive cellular therapy. The primary goals are to: 1) refine the palliative care intervention based on findings from an open pilot study, 2) assess the feasibility and acceptability of the intervention through a pilot...
This federal Project Grant award of $2,808,108.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Sloan-Kettering Institute for Cancer Research to investigate the role of clonal hematopoiesis in therapeutic resistance and metastatic relapse in breast cancer. The award period extends from March 1, 2024 to February 29, 2028. Through this funding, the Sloan-Kettering Institute will explore the...
This $1,290,499 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a research project led by the Dana-Farber Cancer Institute, Inc. (Dfci) in Boston, MA. The project is studying the effect of clonal hematopoiesis on cardiovascular-related outcomes in patients diagnosed with kidney cancer. The four-year research effort, which commenced on September 1, 2023 and is scheduled for completion by August 31, 2027, aims to advance...
The National Cancer Institute (NCI) awarded a Project Grant (CFDA 93.395 - Cancer Treatment Research) to Northwestern University totaling $716,911 starting on August 1, 2024. The grant will fund a 2-arm randomized controlled trial to evaluate the efficacy of the MOSAIC digital health intervention, which delivers peer support narratives and psychoeducation to English- and Spanish-speaking stem cell transplant (SCT) recipients. The goal is to reduce psychological distress and improve other...
This federal Project Grant award in the amount of $5,339,958, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the development of a digital health intervention for self-management and telemonitoring in chimeric antigen receptor (CAR)-T cell therapy. The award, with a performance period from June 2025 to June 2029, is provided to the Beckman Research Institute of the City of Hope, a nonprofit medical research organization....
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), will support research on improving the safety and efficacy of chemoradiotherapy for locally advanced head and neck squamous cell carcinoma and anaplastic thyroid cancer. The key products/services to be delivered include: Evaluating how fractionated radiation affects the tumor microenvironment and impacts passive drug delivery, using in vivo imaging, microscopy, and...